Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine

NCT00176436 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT00176436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00176436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
March 31, 2008
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia